Foresight Health® Acral Mutilation Syndrome

£42.00

Our Foresight Health® single test for Acral Mutilation Syndrome is ideal for breeders and owners who want the reassurance of genetic health testing.

Our DNA test results are accepted by the Kennel Club.

Description

Acral Mutilation Syndrome (AMS) can result in an insensitivity to pain and self-mutilation of the limb extremities. This can present as extreme licking of the paws and biting of the digits and claws developing from a young age (3-12 months). It is possible for a genetically at-risk dog to exhibit none of the symptoms of this syndrome.

Acral Mutilation Syndrome is an autosomal recessive condition caused by a mutation in the GDNF gene.

Breeds

This test is also included in the following Foresight Health® breed packages:

 

The guideline turnaround time for single tests is approximately 10-12 working days after the swab arrives at the lab. 

If you need more than two tests it is often more cost-effective to order the relevant Foresight Health® breed package.


Scientific references:

Plassais, J., Lagoutte, L., Correard, S., Paradis, M., Guaguère, E., Hédan, B., Pommier, A., Botherel, N., Cadiergues, M. C., Pilorge, P., Silversides, D., Bizot, M., Samuels, M., Arnan, C., Johnson, R., Hitte, C., Salbert, G., Méreau, A., Quignon, P., Derrien, T., … André, C. (2016). A Point Mutation in a lincRNA Upstream of GDNF Is Associated to a Canine Insensitivity to Pain: A Spontaneous Model for Human Sensory Neuropathies. PLoS genetics12(12), e1006482.

Correard, Solenne; Plassais, Jocelyn; Lagoutte, Laëtitia ; Paradis, Manon ; Guaguère, Éric ; Quignon, Pascale ; Derrien, Thomas ; André, Catherine. (2016) A spontaneous dog model for a human sensory neuropathy: identification of a mutation in the upstream region of a neurotrophic factor. Bulletin de l'Académie vétérinaire de France, 169 (3), p. 190-194

You recently viewed

Clear recently viewed